ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1635

Deep Learning Accurately Predicts Focus Score and Diagnosis of Primary Sjögren Syndrome Using Labial Salivary Gland Biopsies

Louis Basseto1, Julien Duquesne1, Michael Barnes2, Elena Pontarini2, Amaya Gallagher-Syed2, Michele Bombardieri2, Benjamin A Fisher3, Saba Nayar3, Clovis Adam4, Thierry Lazure4, Xavier Mariette5, Samuel Bitoun6 and Vincent Bouget1, 1Scienta Lab, Paris, France, 2Queen Mary University of London, London, United Kingdom, 3University of Birmingham, Birmingham, United Kingdom, 4Université Paris-Saclay, Paris, France, 5Université Paris-Saclay, Le Kremlin-Bicêtre, France, 6CHU Bicêtre APHP, Le Kremlin-Bicêtre, France

Meeting: ACR Convergence 2023

Keywords: Bioinformatics, Biomarkers, Sjögren's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: Abstracts: Sjögren’s Syndrome – Basic & Clinical Science

Session Type: Abstract Session

Session Time: 2:00PM-3:30PM

Background/Purpose: Primary Sjögren Syndrome (pSS) diagnosis relies on the weighted sum of three EULAR/ACR 2016 criteria: i) quantification of lymphocyte infiltration in labial salivary gland (LSG) biopsies, ii) autoantibody status and iii) objective quantification of eye and mouth dryness. Diagnosing pSS is highly challenging and the histological interpretation of LSG tissue requires specific expertise. It poses a challenge to non-specialized centers as highlighted by Vivino et al. [1] who show up to 53% of diagnosis reclassification after expert center rescoring. This analysis is critical and involves the determination of the focus score (FS), where a score ≥1 confirms the histological criteria for pSS. With mounting evidence underlining the potential of artificial intelligence in assisting pathologists, we aimed to develop two deep learning models using LSG biopsies only: one to automatically assess the FS (≥ 1 or < 1), and one to predict pSS diagnosis. Furthermore, we put effort in implementing explainable models highlighting the subregions of the biopsy leveraged for the prediction.

Methods: Deep learning models were developed using digitalized LSG slides from patients from three European expert centers taking part in the NECESSITY consortium, a European H2020 IMI2 project. Three patient groups were included: sicca patients with a FS < 1, pSS patients with a FS ≥ 1, and pSS patients with a FS < 1. All pSS diagnoses were confirmed by rheumatologists from expert centers and satisfied the EULAR/ACR 2016 classification criteria. Models were trained on 70% of the patients and validated on the remaining 30%. Algorithm performance was measured using the area under the receiver operating characteristic curve (AUROC), positive and negative predictive values (PPV and NPV), specificity and sensitivity. The models provide risk scores for each biopsy subregion, these scores explain how predictions of FS and pSS are computed.

Results: The dataset included a total of 325 patients: 145 from Paris-Saclay University (Bicêtre Hospital), 71 from Queen Mary University of London and 109 from the University of Birmingham. In the validation set, the model achieved an AUROC of 0.88 (95% CI 0.85 to 0.90) for binary assessment of the FS (≥ 1 or < 1); and 0.84 (95% CI 0.83 to 0.86) for predicting pSS diagnosis. Analysis of histological subregions selected by the model determining the FS unsurprisingly revealed regions with a high concentration of lymphocytes (Figure 1). Detailed performance results for both models are available in Table 1.

Conclusion: Deep learning can predict both the FS and pSS diagnosis with high accuracy using digitalized LSG slides only. The FS model could serve as a valuable tool to assist pathologists who may not specialize in oral pathology, reducing their reliance on reference centers. Furthermore, this study paves the way for a better understanding of pSS physiopathology: the determination of the regions selected by the algorithm for the diagnosis of pSS in FS negative patients is in progress, with up to now a highlight on lympho-epithelial lesions.

[1] Vivino FB et al. Change in final diagnosis on second evaluation of labial minor salivary gland biopsies. J Rheumatol. 2002 May;29(5):938-44. PMID: 12022353.

Supporting image 1

Table 1: Detailed performance results on the validation set of the models predicting the FS (≥ 1 or < 1) and pSS diagnosis (PPV: positive predictive value, NPV: negative predictive value, mean confidence interval (CI)).

Supporting image 2

Figure 1: LSG biopsy with computed FS ≥ 1 probability (blue is low, red is high). Note that subregions with high-risk score (red; left) highlight lymphocytes aggregates (right).


Disclosures: L. Basseto: None; J. Duquesne: None; M. Barnes: Servier, 2; E. Pontarini: None; A. Gallagher-Syed: None; M. Bombardieri: None; B. A Fisher: Bristol-Myers Squibb(BMS), 2, Celgene, 5, Galapagos, 2, 5, Janssen, 2, 5, Novartis, 2, Roche, 2, Sanofi, 2, Servier, 2, 5, UCB, 2; S. Nayar: None; C. Adam: None; T. Lazure: None; X. Mariette: AstraZeneca, 2, 6, BMS, 2, 6, Galapagos, 2, 6, GSK, 2, 6, Novartis, 2, 6, Pfizer, 2, 6; S. Bitoun: None; V. Bouget: None.

To cite this abstract in AMA style:

Basseto L, Duquesne J, Barnes M, Pontarini E, Gallagher-Syed A, Bombardieri M, A Fisher B, Nayar S, Adam C, Lazure T, Mariette X, Bitoun S, Bouget V. Deep Learning Accurately Predicts Focus Score and Diagnosis of Primary Sjögren Syndrome Using Labial Salivary Gland Biopsies [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/deep-learning-accurately-predicts-focus-score-and-diagnosis-of-primary-sjogren-syndrome-using-labial-salivary-gland-biopsies/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/deep-learning-accurately-predicts-focus-score-and-diagnosis-of-primary-sjogren-syndrome-using-labial-salivary-gland-biopsies/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology